Global Companion Animal Speciality Drugs

Companion Animal Speciality Drugs Comprehensive Study by Type (Antibiotics, Anti-inflammatory Drugs, Parasiticides, Heartworm, Behavioural Products, Nutritional Products, Anti-Obesity Drugs, Skin Care Products, Vaccines), Application (Hospital, Clinic, Others) Players and Region - Global Market Outlook to 2026

Companion Animal Speciality Drugs Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Companion Animal Speciality Drugs Market Overview:


Growth Drivers
  • Increase Number of Urbanization Boost the Companion Animal Speciality Drugs Market.
  • Rise in Number of Nuclear Families.

Roadblocks
  • Inability to Understand Behavioral Symptoms of Diseases Hampers the Market.
  • Lack of Medications for Certain Diseases Associated With in Companion Animal Speciality Drugs Market.

Opportunities
  • Proliferation of Pet Healthcare Service Leads to Grow The Companion Animal Speciality Drugs Market.
  • Upsurge Demand of Awareness Among The Customers.

Challenges
  • Limitation on the Government Regulation in Companion Animal Speciality Drugs are Anticipated to Challenge the Market.


Competitive Landscape:

Some of the key players profiled in the report are Zoetis, Inc. (United States), Merck & Co., Inc. (United States), Bayer AG (Germany), Elanco (India), Boehringer Ingelheim Animal Health Gmbh (Germany) and Ceva Sante Animale S.A. (United States). Additionally, following companies can also be profiled that are part of our coverage like Aratana therapeutics (United States) and The J.M Smucker Company (United States). Analyst at AMA Research see United States Vendors to retain maximum share of Global Companion Animal Speciality Drugs market by 2026.

In April 2019, Elanco launched a commercial team that specifically dedicated to veterinary specialty products which is beneficial in providing opportunity to animal therapeutics business. It also offers treatment for lymphoma in dogs.

What Can be Explored with the Companion Animal Speciality Drugs Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Companion Animal Speciality Drugs Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Companion Animal Speciality Drugs
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Companion Animal Speciality Drugs market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Companion Animal Speciality Drugs market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Companion Animal Speciality Drugs Manufacturers, Companion Animal Speciality Drugs Traders, End-Use Market Participants of Different Segments of Companion Animal Speciality Drugs, Government and Research Organizations, R&D Institutions and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Type
  • Antibiotics
  • Anti-inflammatory Drugs
  • Parasiticides
  • Heartworm
  • Behavioural Products
  • Nutritional Products
  • Anti-Obesity Drugs
  • Skin Care Products
  • Vaccines
By Application
  • Hospital
  • Clinic
  • Others
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase Number of Urbanization Boost the Companion Animal Speciality Drugs Market.
      • 3.2.2. Rise in Number of Nuclear Families.
    • 3.3. Market Challenges
      • 3.3.1. Limitation on the Government Regulation in Companion Animal Speciality Drugs are Anticipated to Challenge the Market.
    • 3.4. Market Trends
      • 3.4.1. Value Oriented Consumers
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Companion Animal Speciality Drugs, by Type, Application and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Companion Animal Speciality Drugs (Value)
      • 5.2.1. Global Companion Animal Speciality Drugs by: Type (Value)
        • 5.2.1.1. Antibiotics
        • 5.2.1.2. Anti-inflammatory Drugs
        • 5.2.1.3. Parasiticides
        • 5.2.1.4. Heartworm
        • 5.2.1.5. Behavioural Products
        • 5.2.1.6. Nutritional Products
        • 5.2.1.7. Anti-Obesity Drugs
        • 5.2.1.8. Skin Care Products
        • 5.2.1.9. Vaccines
      • 5.2.2. Global Companion Animal Speciality Drugs by: Application (Value)
        • 5.2.2.1. Hospital
        • 5.2.2.2. Clinic
        • 5.2.2.3. Others
      • 5.2.3. Global Companion Animal Speciality Drugs Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Companion Animal Speciality Drugs (Price)
      • 5.3.1. Global Companion Animal Speciality Drugs by: Type (Price)
  • 6. Companion Animal Speciality Drugs: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Zoetis, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Merck & Co., Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Bayer AG (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Elanco (India)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Boehringer Ingelheim Animal Health Gmbh (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Ceva Sante Animale S.A. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
  • 7. Global Companion Animal Speciality Drugs Sale, by Type, Application and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Companion Animal Speciality Drugs (Value)
      • 7.2.1. Global Companion Animal Speciality Drugs by: Type (Value)
        • 7.2.1.1. Antibiotics
        • 7.2.1.2. Anti-inflammatory Drugs
        • 7.2.1.3. Parasiticides
        • 7.2.1.4. Heartworm
        • 7.2.1.5. Behavioural Products
        • 7.2.1.6. Nutritional Products
        • 7.2.1.7. Anti-Obesity Drugs
        • 7.2.1.8. Skin Care Products
        • 7.2.1.9. Vaccines
      • 7.2.2. Global Companion Animal Speciality Drugs by: Application (Value)
        • 7.2.2.1. Hospital
        • 7.2.2.2. Clinic
        • 7.2.2.3. Others
      • 7.2.3. Global Companion Animal Speciality Drugs Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Companion Animal Speciality Drugs (Price)
      • 7.3.1. Global Companion Animal Speciality Drugs by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Companion Animal Speciality Drugs: by Type(USD Million)
  • Table 2. Companion Animal Speciality Drugs Antibiotics , by Region USD Million (2015-2020)
  • Table 3. Companion Animal Speciality Drugs Anti-inflammatory Drugs , by Region USD Million (2015-2020)
  • Table 4. Companion Animal Speciality Drugs Parasiticides , by Region USD Million (2015-2020)
  • Table 5. Companion Animal Speciality Drugs Heartworm , by Region USD Million (2015-2020)
  • Table 6. Companion Animal Speciality Drugs Behavioural Products , by Region USD Million (2015-2020)
  • Table 7. Companion Animal Speciality Drugs Nutritional Products , by Region USD Million (2015-2020)
  • Table 8. Companion Animal Speciality Drugs Anti-Obesity Drugs , by Region USD Million (2015-2020)
  • Table 9. Companion Animal Speciality Drugs Skin Care Products , by Region USD Million (2015-2020)
  • Table 10. Companion Animal Speciality Drugs Vaccines , by Region USD Million (2015-2020)
  • Table 11. Companion Animal Speciality Drugs: by Application(USD Million)
  • Table 12. Companion Animal Speciality Drugs Hospital , by Region USD Million (2015-2020)
  • Table 13. Companion Animal Speciality Drugs Clinic , by Region USD Million (2015-2020)
  • Table 14. Companion Animal Speciality Drugs Others , by Region USD Million (2015-2020)
  • Table 15. South America Companion Animal Speciality Drugs, by Country USD Million (2015-2020)
  • Table 16. South America Companion Animal Speciality Drugs, by Type USD Million (2015-2020)
  • Table 17. South America Companion Animal Speciality Drugs, by Application USD Million (2015-2020)
  • Table 18. Brazil Companion Animal Speciality Drugs, by Type USD Million (2015-2020)
  • Table 19. Brazil Companion Animal Speciality Drugs, by Application USD Million (2015-2020)
  • Table 20. Argentina Companion Animal Speciality Drugs, by Type USD Million (2015-2020)
  • Table 21. Argentina Companion Animal Speciality Drugs, by Application USD Million (2015-2020)
  • Table 22. Rest of South America Companion Animal Speciality Drugs, by Type USD Million (2015-2020)
  • Table 23. Rest of South America Companion Animal Speciality Drugs, by Application USD Million (2015-2020)
  • Table 24. Asia Pacific Companion Animal Speciality Drugs, by Country USD Million (2015-2020)
  • Table 25. Asia Pacific Companion Animal Speciality Drugs, by Type USD Million (2015-2020)
  • Table 26. Asia Pacific Companion Animal Speciality Drugs, by Application USD Million (2015-2020)
  • Table 27. China Companion Animal Speciality Drugs, by Type USD Million (2015-2020)
  • Table 28. China Companion Animal Speciality Drugs, by Application USD Million (2015-2020)
  • Table 29. Japan Companion Animal Speciality Drugs, by Type USD Million (2015-2020)
  • Table 30. Japan Companion Animal Speciality Drugs, by Application USD Million (2015-2020)
  • Table 31. India Companion Animal Speciality Drugs, by Type USD Million (2015-2020)
  • Table 32. India Companion Animal Speciality Drugs, by Application USD Million (2015-2020)
  • Table 33. South Korea Companion Animal Speciality Drugs, by Type USD Million (2015-2020)
  • Table 34. South Korea Companion Animal Speciality Drugs, by Application USD Million (2015-2020)
  • Table 35. Taiwan Companion Animal Speciality Drugs, by Type USD Million (2015-2020)
  • Table 36. Taiwan Companion Animal Speciality Drugs, by Application USD Million (2015-2020)
  • Table 37. Australia Companion Animal Speciality Drugs, by Type USD Million (2015-2020)
  • Table 38. Australia Companion Animal Speciality Drugs, by Application USD Million (2015-2020)
  • Table 39. Rest of Asia-Pacific Companion Animal Speciality Drugs, by Type USD Million (2015-2020)
  • Table 40. Rest of Asia-Pacific Companion Animal Speciality Drugs, by Application USD Million (2015-2020)
  • Table 41. Europe Companion Animal Speciality Drugs, by Country USD Million (2015-2020)
  • Table 42. Europe Companion Animal Speciality Drugs, by Type USD Million (2015-2020)
  • Table 43. Europe Companion Animal Speciality Drugs, by Application USD Million (2015-2020)
  • Table 44. Germany Companion Animal Speciality Drugs, by Type USD Million (2015-2020)
  • Table 45. Germany Companion Animal Speciality Drugs, by Application USD Million (2015-2020)
  • Table 46. France Companion Animal Speciality Drugs, by Type USD Million (2015-2020)
  • Table 47. France Companion Animal Speciality Drugs, by Application USD Million (2015-2020)
  • Table 48. Italy Companion Animal Speciality Drugs, by Type USD Million (2015-2020)
  • Table 49. Italy Companion Animal Speciality Drugs, by Application USD Million (2015-2020)
  • Table 50. United Kingdom Companion Animal Speciality Drugs, by Type USD Million (2015-2020)
  • Table 51. United Kingdom Companion Animal Speciality Drugs, by Application USD Million (2015-2020)
  • Table 52. Netherlands Companion Animal Speciality Drugs, by Type USD Million (2015-2020)
  • Table 53. Netherlands Companion Animal Speciality Drugs, by Application USD Million (2015-2020)
  • Table 54. Rest of Europe Companion Animal Speciality Drugs, by Type USD Million (2015-2020)
  • Table 55. Rest of Europe Companion Animal Speciality Drugs, by Application USD Million (2015-2020)
  • Table 56. MEA Companion Animal Speciality Drugs, by Country USD Million (2015-2020)
  • Table 57. MEA Companion Animal Speciality Drugs, by Type USD Million (2015-2020)
  • Table 58. MEA Companion Animal Speciality Drugs, by Application USD Million (2015-2020)
  • Table 59. Middle East Companion Animal Speciality Drugs, by Type USD Million (2015-2020)
  • Table 60. Middle East Companion Animal Speciality Drugs, by Application USD Million (2015-2020)
  • Table 61. Africa Companion Animal Speciality Drugs, by Type USD Million (2015-2020)
  • Table 62. Africa Companion Animal Speciality Drugs, by Application USD Million (2015-2020)
  • Table 63. North America Companion Animal Speciality Drugs, by Country USD Million (2015-2020)
  • Table 64. North America Companion Animal Speciality Drugs, by Type USD Million (2015-2020)
  • Table 65. North America Companion Animal Speciality Drugs, by Application USD Million (2015-2020)
  • Table 66. United States Companion Animal Speciality Drugs, by Type USD Million (2015-2020)
  • Table 67. United States Companion Animal Speciality Drugs, by Application USD Million (2015-2020)
  • Table 68. Canada Companion Animal Speciality Drugs, by Type USD Million (2015-2020)
  • Table 69. Canada Companion Animal Speciality Drugs, by Application USD Million (2015-2020)
  • Table 70. Mexico Companion Animal Speciality Drugs, by Type USD Million (2015-2020)
  • Table 71. Mexico Companion Animal Speciality Drugs, by Application USD Million (2015-2020)
  • Table 72. Companion Animal Speciality Drugs: by Type(USD/Units)
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Company Basic Information, Sales Area and Its Competitors
  • Table 78. Company Basic Information, Sales Area and Its Competitors
  • Table 79. Companion Animal Speciality Drugs: by Type(USD Million)
  • Table 80. Companion Animal Speciality Drugs Antibiotics , by Region USD Million (2021-2026)
  • Table 81. Companion Animal Speciality Drugs Anti-inflammatory Drugs , by Region USD Million (2021-2026)
  • Table 82. Companion Animal Speciality Drugs Parasiticides , by Region USD Million (2021-2026)
  • Table 83. Companion Animal Speciality Drugs Heartworm , by Region USD Million (2021-2026)
  • Table 84. Companion Animal Speciality Drugs Behavioural Products , by Region USD Million (2021-2026)
  • Table 85. Companion Animal Speciality Drugs Nutritional Products , by Region USD Million (2021-2026)
  • Table 86. Companion Animal Speciality Drugs Anti-Obesity Drugs , by Region USD Million (2021-2026)
  • Table 87. Companion Animal Speciality Drugs Skin Care Products , by Region USD Million (2021-2026)
  • Table 88. Companion Animal Speciality Drugs Vaccines , by Region USD Million (2021-2026)
  • Table 89. Companion Animal Speciality Drugs: by Application(USD Million)
  • Table 90. Companion Animal Speciality Drugs Hospital , by Region USD Million (2021-2026)
  • Table 91. Companion Animal Speciality Drugs Clinic , by Region USD Million (2021-2026)
  • Table 92. Companion Animal Speciality Drugs Others , by Region USD Million (2021-2026)
  • Table 93. South America Companion Animal Speciality Drugs, by Country USD Million (2021-2026)
  • Table 94. South America Companion Animal Speciality Drugs, by Type USD Million (2021-2026)
  • Table 95. South America Companion Animal Speciality Drugs, by Application USD Million (2021-2026)
  • Table 96. Brazil Companion Animal Speciality Drugs, by Type USD Million (2021-2026)
  • Table 97. Brazil Companion Animal Speciality Drugs, by Application USD Million (2021-2026)
  • Table 98. Argentina Companion Animal Speciality Drugs, by Type USD Million (2021-2026)
  • Table 99. Argentina Companion Animal Speciality Drugs, by Application USD Million (2021-2026)
  • Table 100. Rest of South America Companion Animal Speciality Drugs, by Type USD Million (2021-2026)
  • Table 101. Rest of South America Companion Animal Speciality Drugs, by Application USD Million (2021-2026)
  • Table 102. Asia Pacific Companion Animal Speciality Drugs, by Country USD Million (2021-2026)
  • Table 103. Asia Pacific Companion Animal Speciality Drugs, by Type USD Million (2021-2026)
  • Table 104. Asia Pacific Companion Animal Speciality Drugs, by Application USD Million (2021-2026)
  • Table 105. China Companion Animal Speciality Drugs, by Type USD Million (2021-2026)
  • Table 106. China Companion Animal Speciality Drugs, by Application USD Million (2021-2026)
  • Table 107. Japan Companion Animal Speciality Drugs, by Type USD Million (2021-2026)
  • Table 108. Japan Companion Animal Speciality Drugs, by Application USD Million (2021-2026)
  • Table 109. India Companion Animal Speciality Drugs, by Type USD Million (2021-2026)
  • Table 110. India Companion Animal Speciality Drugs, by Application USD Million (2021-2026)
  • Table 111. South Korea Companion Animal Speciality Drugs, by Type USD Million (2021-2026)
  • Table 112. South Korea Companion Animal Speciality Drugs, by Application USD Million (2021-2026)
  • Table 113. Taiwan Companion Animal Speciality Drugs, by Type USD Million (2021-2026)
  • Table 114. Taiwan Companion Animal Speciality Drugs, by Application USD Million (2021-2026)
  • Table 115. Australia Companion Animal Speciality Drugs, by Type USD Million (2021-2026)
  • Table 116. Australia Companion Animal Speciality Drugs, by Application USD Million (2021-2026)
  • Table 117. Rest of Asia-Pacific Companion Animal Speciality Drugs, by Type USD Million (2021-2026)
  • Table 118. Rest of Asia-Pacific Companion Animal Speciality Drugs, by Application USD Million (2021-2026)
  • Table 119. Europe Companion Animal Speciality Drugs, by Country USD Million (2021-2026)
  • Table 120. Europe Companion Animal Speciality Drugs, by Type USD Million (2021-2026)
  • Table 121. Europe Companion Animal Speciality Drugs, by Application USD Million (2021-2026)
  • Table 122. Germany Companion Animal Speciality Drugs, by Type USD Million (2021-2026)
  • Table 123. Germany Companion Animal Speciality Drugs, by Application USD Million (2021-2026)
  • Table 124. France Companion Animal Speciality Drugs, by Type USD Million (2021-2026)
  • Table 125. France Companion Animal Speciality Drugs, by Application USD Million (2021-2026)
  • Table 126. Italy Companion Animal Speciality Drugs, by Type USD Million (2021-2026)
  • Table 127. Italy Companion Animal Speciality Drugs, by Application USD Million (2021-2026)
  • Table 128. United Kingdom Companion Animal Speciality Drugs, by Type USD Million (2021-2026)
  • Table 129. United Kingdom Companion Animal Speciality Drugs, by Application USD Million (2021-2026)
  • Table 130. Netherlands Companion Animal Speciality Drugs, by Type USD Million (2021-2026)
  • Table 131. Netherlands Companion Animal Speciality Drugs, by Application USD Million (2021-2026)
  • Table 132. Rest of Europe Companion Animal Speciality Drugs, by Type USD Million (2021-2026)
  • Table 133. Rest of Europe Companion Animal Speciality Drugs, by Application USD Million (2021-2026)
  • Table 134. MEA Companion Animal Speciality Drugs, by Country USD Million (2021-2026)
  • Table 135. MEA Companion Animal Speciality Drugs, by Type USD Million (2021-2026)
  • Table 136. MEA Companion Animal Speciality Drugs, by Application USD Million (2021-2026)
  • Table 137. Middle East Companion Animal Speciality Drugs, by Type USD Million (2021-2026)
  • Table 138. Middle East Companion Animal Speciality Drugs, by Application USD Million (2021-2026)
  • Table 139. Africa Companion Animal Speciality Drugs, by Type USD Million (2021-2026)
  • Table 140. Africa Companion Animal Speciality Drugs, by Application USD Million (2021-2026)
  • Table 141. North America Companion Animal Speciality Drugs, by Country USD Million (2021-2026)
  • Table 142. North America Companion Animal Speciality Drugs, by Type USD Million (2021-2026)
  • Table 143. North America Companion Animal Speciality Drugs, by Application USD Million (2021-2026)
  • Table 144. United States Companion Animal Speciality Drugs, by Type USD Million (2021-2026)
  • Table 145. United States Companion Animal Speciality Drugs, by Application USD Million (2021-2026)
  • Table 146. Canada Companion Animal Speciality Drugs, by Type USD Million (2021-2026)
  • Table 147. Canada Companion Animal Speciality Drugs, by Application USD Million (2021-2026)
  • Table 148. Mexico Companion Animal Speciality Drugs, by Type USD Million (2021-2026)
  • Table 149. Mexico Companion Animal Speciality Drugs, by Application USD Million (2021-2026)
  • Table 150. Companion Animal Speciality Drugs: by Type(USD/Units)
  • Table 151. Research Programs/Design for This Report
  • Table 152. Key Data Information from Secondary Sources
  • Table 153. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Companion Animal Speciality Drugs: by Type USD Million (2015-2020)
  • Figure 5. Global Companion Animal Speciality Drugs: by Application USD Million (2015-2020)
  • Figure 6. South America Companion Animal Speciality Drugs Share (%), by Country
  • Figure 7. Asia Pacific Companion Animal Speciality Drugs Share (%), by Country
  • Figure 8. Europe Companion Animal Speciality Drugs Share (%), by Country
  • Figure 9. MEA Companion Animal Speciality Drugs Share (%), by Country
  • Figure 10. North America Companion Animal Speciality Drugs Share (%), by Country
  • Figure 11. Global Companion Animal Speciality Drugs: by Type USD/Units (2015-2020)
  • Figure 12. Global Companion Animal Speciality Drugs share by Players 2020 (%)
  • Figure 13. Global Companion Animal Speciality Drugs share by Players (Top 3) 2020(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Zoetis, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 16. Zoetis, Inc. (United States) Revenue: by Geography 2020
  • Figure 17. Merck & Co., Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 18. Merck & Co., Inc. (United States) Revenue: by Geography 2020
  • Figure 19. Bayer AG (Germany) Revenue, Net Income and Gross profit
  • Figure 20. Bayer AG (Germany) Revenue: by Geography 2020
  • Figure 21. Elanco (India) Revenue, Net Income and Gross profit
  • Figure 22. Elanco (India) Revenue: by Geography 2020
  • Figure 23. Boehringer Ingelheim Animal Health Gmbh (Germany) Revenue, Net Income and Gross profit
  • Figure 24. Boehringer Ingelheim Animal Health Gmbh (Germany) Revenue: by Geography 2020
  • Figure 25. Ceva Sante Animale S.A. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Ceva Sante Animale S.A. (United States) Revenue: by Geography 2020
  • Figure 27. Global Companion Animal Speciality Drugs: by Type USD Million (2021-2026)
  • Figure 28. Global Companion Animal Speciality Drugs: by Application USD Million (2021-2026)
  • Figure 29. South America Companion Animal Speciality Drugs Share (%), by Country
  • Figure 30. Asia Pacific Companion Animal Speciality Drugs Share (%), by Country
  • Figure 31. Europe Companion Animal Speciality Drugs Share (%), by Country
  • Figure 32. MEA Companion Animal Speciality Drugs Share (%), by Country
  • Figure 33. North America Companion Animal Speciality Drugs Share (%), by Country
  • Figure 34. Global Companion Animal Speciality Drugs: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Zoetis, Inc. (United States)
  • Merck & Co., Inc. (United States)
  • Bayer AG (Germany)
  • Elanco (India)
  • Boehringer Ingelheim Animal Health Gmbh (Germany)
  • Ceva Sante Animale S.A. (United States)
Additional players considered in the study are as follows:
Aratana therapeutics (United States) , The J.M Smucker Company (United States)
Select User Access Type

Key Highlights of Report


Jul 2021 212 Pages 89 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Companion Animal Speciality Drugs Quantitative research analysis
Global Companion Animal Speciality Drugs Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Companion Animal Speciality Drugs market is expected to see a CAGR of % during projected year 2020 to 2026.
Top performing companies in the Global Companion Animal Speciality Drugs market are Zoetis, Inc. (United States), Merck & Co., Inc. (United States), Bayer AG (Germany), Elanco (India), Boehringer Ingelheim Animal Health Gmbh (Germany) and Ceva Sante Animale S.A. (United States), to name a few.
"Value Oriented Consumers" is seen as one of major influencing trends for Companion Animal Speciality Drugs Market during projected period 2020-2026.

Know More About Global Companion Animal Speciality Drugs Report?

Have a Query? Click Here

Other Related Reports

Smart Home as a Service Comprehensive Study by Type (Integrated Services, Managed Services), Application (Personal Use, Commercial Use), Solution (Smoke and Fire Monitoring, E-Health, Lighting & Wind...
$ 3650
Driver Safety Systems Comprehensive Study by Type (Passive ADAS systems, Active ADAS systems, Automates the enhancement of safety systems, Actions adaptive features, Helps in the perception of traffi...
$ 3750
Legal Services Comprehensive Study by Type (B2B Legal Services, B2C Legal Services, Criminal Law Practices, Hybrid Commercial Legal Services), Application (Finance, Manufacturing, Energy & Utilities,...
$ 3650
Domestic Express Service Comprehensive Study by Application (Non Documented, Documented, Dutiable Items, Healthcare, Food, Other), Functionality (Internet-Based Track And Trace System, Delivery Infor...
$ 3750
Packaged Food Traceability Comprehensive Study by Application (Frozen Food, Fresh Food, Dairy Product, Beverage), Equipment (PDA with GPS, Thermal Printers, 2D & 1D Scanners, Tags & Labels, Sensors, ...
$ 3750
Cosmetic and Personal Care Stores Comprehensive Study by Type (Makeup & Cosmetics, Skin Care, Hair Care, Others), End user (Men, Women) Players and Region - Global Market Outlook to 2026
$ 3500